DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Pengo V, Banzato A, Bison E, Zoppellaro G, Padayattil Jose S, Denas G.
Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial.
Lupus 2016;
25 (03) 301-306
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.